These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 20676736

  • 21. Solubility profiling of HIV protease inhibitors in human intestinal fluids.
    Wuyts B, Brouwers J, Mols R, Tack J, Annaert P, Augustijns P.
    J Pharm Sci; 2013 Oct; 102(10):3800-7. PubMed ID: 23939880
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
    Niederquell A, Kuentz M.
    J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
    [Abstract] [Full Text] [Related]

  • 27. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
    Khoshakhlagh P, Johnson R, Langguth P, Nawroth T, Schmueser L, Hellmann N, Decker H, Szekely NK.
    J Pharm Sci; 2015 Jul; 104(7):2213-24. PubMed ID: 25964103
    [Abstract] [Full Text] [Related]

  • 28. Importance of critical micellar concentration for the prediction of solubility enhancement in biorelevant media.
    Ottaviani G, Wendelspiess S, Alvarez-Sánchez R.
    Mol Pharm; 2015 Apr 06; 12(4):1171-9. PubMed ID: 25665011
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Drug solubilization in dog intestinal fluids with and without administration of lipid-based formulations.
    Parrow A, Kabedev A, Larsson P, Johansson P, Abrahamsson B, Bergström CAS.
    J Control Release; 2024 Jul 06; 371():555-569. PubMed ID: 38844179
    [Abstract] [Full Text] [Related]

  • 31. Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid.
    Takács-Novák K, Szőke V, Völgyi G, Horváth P, Ambrus R, Szabó-Révész P.
    J Pharm Biomed Anal; 2013 Sep 06; 83():279-85. PubMed ID: 23770783
    [Abstract] [Full Text] [Related]

  • 32. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
    Augustijns P, Wuyts B, Hens B, Annaert P, Butler J, Brouwers J.
    Eur J Pharm Sci; 2014 Jun 16; 57():322-32. PubMed ID: 23994640
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Exploring the Impact of Intestinal Fluid Components on the Solubility and Supersaturation of Danazol.
    Madsen CM, Plum J, Hens B, Augustijns P, Müllertz A, Rades T.
    J Pharm Sci; 2021 Jun 16; 110(6):2479-2488. PubMed ID: 33428916
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of Dissolution in the Lower Intestine and Its Impact on the Absorption Process of High Dose Low Solubility Drugs.
    Georgaka D, Butler J, Kesisoglou F, Reppas C, Vertzoni M.
    Mol Pharm; 2017 Dec 04; 14(12):4181-4191. PubMed ID: 28366005
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M, Fukahori M, Ikemura A, Kubota A, Higashino H, Sakuma S, Yamashita S.
    Eur J Pharm Biopharm; 2016 Apr 04; 101():103-11. PubMed ID: 26873006
    [Abstract] [Full Text] [Related]

  • 38. Characterisation of fasted state gastric and intestinal fluids collected from children.
    Pawar G, Papadatou-Soulou E, Mason J, Muhammed R, Watson A, Cotter C, Abdallah M, Harrad S, Mackie C, Arien T, Inghelbrecht S, Batchelor H.
    Eur J Pharm Biopharm; 2021 Jan 04; 158():156-165. PubMed ID: 33259897
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.